Form 4: UTHR Director Causey Exercises Options, Sells 1,000 Shares

United Therapeutics Director Christopher Causey exercised options and sold 1,000 shares.

Summary

• Christopher Causey, a Director at United Therapeutics Corp (UTHR), engaged in transactions involving the company's common stock.
• On September 24, 2025, Causey exercised 1,000 stock options at an exercise price of $119.76 per share.
• Concurrently, Causey sold 1,000 shares of common stock on the open market at a price of $440 per share.
• Following these transactions, Causey beneficially owns 4,865 shares of common stock directly.
• Causey also beneficially owns 9,320 stock options directly after the reported transactions.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where a director exercised stock options and immediately sold an equivalent number of shares, realizing a substantial profit. This is a common liquidity event for insiders and does not inherently signal strong positive or negative company performance.

Positives

• Director Causey realized a significant profit from the exercise of stock options and subsequent sale of shares, with a difference of $320.24 per share between the exercise price ($119.76) and the sale price ($440).

Negatives

• The sale of 1,000 shares by a director, while a common liquidity event, could be perceived as a minor negative signal by some investors, though the volume is relatively small.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The transaction represents a director monetizing a portion of their equity compensation, which is a common practice. The relatively small volume of shares sold is unlikely to have a significant impact on the broader shareholder base.

Key Dates

Keywords

United Therapeutics, UTHR, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, Christopher Causey